15 Cheap Beginner Stocks to Buy
In this article, we will take a look at 15 cheap stocks to buy now for beginners.
Posts Tagged ‘NASDAQ:BIIB’
5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 5 most undervalued healthcare stocks to buy according to hedge funds.
Biogen Inc. (NASDAQ:BIIB) Q4 2022 Earnings Call Transcript
Operator: Good morning. My name is Bettina , and I will be your conference operator today.
15 Biggest Neuroscience Companies in the World
In this article, we will discuss the 15 Biggest Neuroscience Companies in the World.
5 Most Undervalued Quality Stocks To Buy According To Hedge Funds
In this article, we discuss 5 most undervalued quality stocks to buy according to hedge funds.
5 Best Healthcare Stocks For Recession
McKesson Corporation (NYSE:MCK) is one of the most notable healthcare companies in the US.
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks.
15 Best S&P 500 Stocks That Don’t Pay Dividends
In this article, we will be taking a look at the 15 best S&P 500 stocks that don't pay dividends.
5 Best Immunology Stocks to Invest In
In this article, we discuss the 5 best immunology stocks to invest in.
5 Richest Hedge Fund Managers in the World
In this article, we discuss 5 richest hedge fund managers in the world.
5 Most Famous Investment Gurus of All Time
In this article, we discuss 5 most famous investment gurus of all time.
5 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Here’s Why Biogen (BIIB) Outperformed in the Quarter
ClearBridge Investments, an investment management company, released its “ClearBridge Aggressive Growth Strategy” third quarter 2022 investor letter.
15 Best Drug Stocks to Buy Now
According to the International Federation of Pharmaceuticals Manufacturers & Associations, the global pharmaceutical sector or the drug industry is expected to post annual revenues...
12 Best Ethical Stocks To Buy Now
In this article, we will take a look at 12 best ethical stocks to buy now.
25 Biggest Pharmaceutical Companies in the World A Year Ago
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
10 Best Biotech Stocks To Buy Now
In this article, we will take a look at the 10 best Biotech stocks to buy now.
Top 10 Stock Picks of Efrem Kamen’s Pura Vida Investments
In this article, we shall be going through the top 10 stock picks of Efrem Kamen's Pura Vida Investments.
These 10 Companies Upped Guidance Despite Global Economic Headwinds
In this article, we will discuss the 10 companies that just raised their guidance despite global economic headwinds.
5 Companies that Recently Raised Guidance
In this article, we discuss 5 companies that recently raised their guidance.
5 Most Anticipated Earnings to Watch on Wednesday
In this article, we discuss the 5 most anticipated earnings to watch on Wednesday.
15 Best Drug Stocks To Buy Now
The pharmaceutical industry is thriving globally, and it was given a healthy boost by the COVID-19 vaccine rollouts around the world.
10 Stocks to Watch on Friday
It’s a mixed day at the stock market as the investors are trying to anticipate the next policy move by the Federal Reserve.
10 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at ten biotechnology stocks to buy according to billionaire DE Shaw.
5 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management. If you want to learn about Mr.
10 Biotech Stocks Hedge Funds Are Talking About
In this article, we present the list of the 10 biotech stocks hedge funds are talking about.
10 Large-Cap Stocks Hedge Funds Are Talking About
In this article, we will share the insights on 10 large-cap stocks hedge funds are talking about.
Is Biogen (BIIB) A Great Long-Term Buy?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Fund” fourth quarter 2021 investor letter – a copy of...
5 Stocks Making Headlines Following Earnings Reports
In this article, we discuss the 5 stocks making headlines following earnings reports.
10 Biotech Stocks to Buy According to Matthew Strobeck’s Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Were Hedge Funds Right About Biogen Inc. (BIIB)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Here is What Hedge Funds Think About Biogen Inc. (BIIB)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
5 Best Beaten Down Stocks To Buy Today
In this article, we discuss the 5 best beaten down stocks to buy today.
Was The Smart Money Right About Biogen Inc. (BIIB)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
5 Stocks Making Moves on Financial Results
In this article, we discuss the 5 stocks making moves on financial results.
5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.
Growth Stock Portfolio: 10 Stock Picks By Hedge Funds
In this article, we discuss the 10 growth stock picks by hedge funds.
Paul Marshall and Ian Wace’s Stock Picks: Biogen Inc (BIIB), Apple Inc (AAPL) and More
In this article, we discuss Paul Marshall and Ian Wace's 10 stock picks: Biogen Inc (BIIB), Apple Inc (AAPL) and More based on Q2 holdings of the fund.
Hedge Funds Are Buying Biogen Inc. (BIIB)
In this article you are going to find out whether hedge funds think Biogen Inc. (NASDAQ:BIIB) is a good investment right now.
Why These 5 Stocks Are on the Move on Wednesday
In this article we take a look at five stocks on the move on Wednesday.
Is Biogen (BIIB) A Good Stock To Buy Now?
Miller Value Partners recently released its Q2 2021 Investor Letter, a copy of which you can download here.
Is Biogen (BIIB) A Good Stock To Buy?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, recently released its Q2 2021 Investor Letter, a copy of which you can download here.
Warren Buffett Is Selling These 5 Stocks
In this article, we discuss the 5 stocks Warren Buffett is selling.
Is Biogen (BIIB) A Great Investment Pick?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Global Fund” second quarter 2021 investor letter – a copy...
Were Hedge Funds Right About Biogen Inc. (BIIB)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world.
Is Biogen (BIIB) A Smart Investment Choice?
ClearBridge Investments, an investment management firm, published its “Aggressive Growth Strategy” second quarter 2021 investor letter – a copy of which can be downloaded...
Where Do Hedge Funds Stand On Biogen Inc. (BIIB)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Biogen (BIIB) A Good Stock To Buy?
ClearBridge Investments, an investment management firm, published its “All Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here...
Is It Too Late to Buy Biogen (BIIB) Stock?
Del Principe O’Brien Financial Advisors recently released its March 2021 investor letter – a copy of which is available for download here.
